Acute and sub-acute oral toxicity assessment of 5-hydroxy-1,4-naphthoquinone in mice

References

• Ahmad, T., and Suzuki, Y.J., 2019. Juglone in oxidative stress and cell signaling. Antioxidants, 8 (4), 91.
   Web of Science ®Google Scholar
• Aithal, K.B., et al., 2012. Tumor growth inhibitory effect of juglone and its radiation sensitizing potential: in vivo and in vitro studies. Integrative Cancer Therapies, 11 (1), 68–80.
   PubMed Web of Science ®Google Scholar
• Aithal, B.K., et al., 2011. Evaluation of pharmacokinetic, biodistribution, pharmacodynamic, and toxicity profile of free juglone and its sterically stabilized liposomes. Journal of Pharmaceutical Sciences, 100 (8), 3517–3528.
   PubMed Web of Science ®Google Scholar
• Anaissi-Afonso, L., et al., 2018. Lawsone, juglone, and β-lapachone derivatives with enhanced mitochondrial-based toxicity. ACS Chemical Biology, 13 (8), 1950–1957.
   PubMed Web of Science ®Google Scholar
• Baralić, K., et al., 2020. Relevance and evaluation of the benchmark dose in toxicology. Arhiv za Farmaciju, 70 (3), 130–141.
   Google Scholar
• Bello, O.A., et al., 2018. A review study on phytochemistry and pharmacology applications of Juglans regia plant. Pharmacognosy Reviews, 1 (2), 8–15.
   Google Scholar
• Boelkins, J.N., Everson, L.K., and Auyong, T.K., 1968. Effects of intravenous juglone in the dog. Toxicon : Official Journal of the International Society on Toxinology, 6 (2), 99–102.
   PubMed Web of Science ®Google Scholar
• Bolton, J.L., et al., 2000. Role of quinones in toxicology. Chemical Research in Toxicology, 13 (3), 135–160.
   PubMed Web of Science ®Google Scholar
• Buist, H.E., et al., 2009. Derivation of the minimal magnitude of the Critical Effect Size for continuous toxicological parameters from within-animal variation in control group data. Regulatory Toxicology and Pharmacology : RTP, 55 (2), 139–150.
   PubMed Web of Science ®Google Scholar
• Catanzaro, E., et al., 2018. Natural products to fight cancer: a focus on Juglans regia. Toxins, 10 (11), 469.
   PubMed Web of Science ®Google Scholar
• Chen, L.J., Lebetkin, E.H., and Burka, L.T., 2005. Metabolism and disposition of juglone in male F344 rats. Xenobiotica; the Fate of Foreign Compounds in Biological Systems, 35 (10–11), 1019–1034.
   PubMed Web of Science ®Google Scholar
• Conducting a Human Health Risk Assessment | US EPA [online], 2022. Available from: https://www.epa.gov/risk/conducting-human-health-risk-assessment [Accessed 3 Jun 2022].
   Google Scholar
• Crump, K.S., 1995. Calculation of benchmark doses from continuous data. Risk Analysis, 15 (1), 79–89.
   Web of Science ®Google Scholar
• Crump, K. S., 2008. Benchmark analysis. In: Encyclopedia of quantitative risk analysis and assessment. Chichester, UK: John Wiley & Sons, Ltd.
   Google Scholar
• Cui, J., and Jia, J., 2021. Discovery of juglone and its derivatives as potent SARS-CoV-2 main proteinase inhibitors. European Journal of Medicinal Chemistry, 225, 113789.
   PubMed Web of Science ®Google Scholar
• Dekkers, S., et al., 2006. Within-animal variation as an indication of the minimal magnitude of the critical effect size for continuous toxicological parameters applicable in the benchmark dose approach. Risk Analysis : An Official Publication of the Society for Risk Analysis, 26 (4), 867–880.
   PubMed Web of Science ®Google Scholar
• Fentener van Vlissingen, J., et al., 2015. The reporting of clinical signs in laboratory animals. Laboratory Animals, 49 (4), 267–283.
   PubMed Web of Science ®Google Scholar
• Gaikwad, S., et al., 2019. Potential immunomodulatory effect of allelochemical juglone in mice vaccinated with BCG. Toxicon : Official Journal of the International Society on Toxinology, 157, 43–52.
   PubMed Web of Science ®Google Scholar
• Gumus, B., et al., 2020. The battle against biofilm infections: juglone loaded nanoparticles as an anticandidal agent. Journal of Biotechnology, 316, 17–26.
   PubMed Web of Science ®Google Scholar
• Haber, L.T., et al., 2018. Benchmark dose (BMD) modeling: current practice, issues, and challenges. Critical Reviews in Toxicology, 48 (5), 387–415.
   PubMed Web of Science ®Google Scholar
• Hardy, A., et al., 2017. Update: use of the benchmark dose approach in risk assessment. EFSA Journal, 15 (1), e04658.
   PubMed Web of Science ®Google Scholar
• Jahanban-Esfahlan, A., et al., 2019. A comprehensive review on the chemical constituents and functional uses of walnut (Juglans spp.) husk. International Journal of Molecular Sciences, 20 (16), 3920.
   PubMed Web of Science ®Google Scholar
• Jha, B.K., et al., 2015. Juglone induces cell death of Acanthamoeba through increased production of reactive oxygen species. Experimental Parasitology, 159, 100–106.
   PubMed Web of Science ®Google Scholar
• Ji, Y., et al., 2010. Effects of juglone on ROS production and mitochondrial transmembrane potential in SGC-7901 cells. 2010 4th International Conference on Bioinformatics and Biomedical Engineering, iCBBE 2010. Chengdu, China.
   Google Scholar
• Juglone | C10H6O3 - PubChem [online], 2021. Available from: https://pubchem.ncbi.nlm.nih.gov/compound/3806 [Accessed 3 Aug 2021].
   Google Scholar
• Kao, C.C., et al., 2021. Juglone prevents human platelet aggregation through inhibiting Akt and protein disulfide isomerase. Phytomedicine : International Journal of Phytotherapy and Phytopharmacology, 82, 153449.
   PubMed Web of Science ®Google Scholar
• Kim, N.H., et al., 2020. Juglone suppresses LPS-induced inflammatory responses and nlrp3 activation in macrophages. Molecules, 25 (13), 3104–3112.
   PubMed Web of Science ®Google Scholar
• Kiran Aithal, B., et al., 2009. Juglone, a naphthoquinone from walnut, exerts cytotoxic and genotoxic effects against cultured melanoma tumor cells. Cell Biology International, 33 (10), 1039–1049.
   PubMed Web of Science ®Google Scholar
• Klotz, L.O., Hou, X., and Jacob, C., 2014. 1,4-naphthoquinones: from oxidative damage to cellular and inter-cellular signaling. Molecules (Basel, Switzerland), 19 (9), 14902–14918.
   PubMed Web of Science ®Google Scholar
• Lou, P., et al., 2007. Mitochondrial uncouplers with an extraordinary dynamic range. The Biochemical Journal, 407 (1), 129–140.
   PubMed Web of Science ®Google Scholar
• Majiene, D., et al., 2019. Comparison of the effect of native 1,4-naphthoquinones plumbagin, menadione, and lawsone on viability, redox status, and mitochondrial functions of C6 glioblastoma cells. Nutrients, 11 (6), 1294.
   PubMed Web of Science ®Google Scholar
• McCoy, R.M., et al., 2018. The origin and biosynthesis of the naphthalenoid moiety of juglone in black walnut. Horticulture Research, 5 (1), 67.
   PubMed Web of Science ®Google Scholar
• Mesalam, A.A., et al., 2020. Induction of oxidative stress and mitochondrial dysfunction by juglone affects the development of bovine oocytes. International Journal of Molecular Sciences, 22 (1), 168–114.
   PubMed Web of Science ®Google Scholar
• Moghadaszadeh, M., et al., 2021. Scolicidal and apoptotic activities of 5-hydroxy-1, 4-naphthoquinone as a potent agent against Echinococcus granulosus protoscoleces. Pharmaceuticals ( Pharmaceuticals), 14 (7), 623.
   Web of Science ®Google Scholar
• Monks, T.J., and Lau, S.S., 1992. Toxicology of quinone-thioethers. Critical Reviews in Toxicology, 22 (5-6), 243–270. http://dx.doi.org/10.3109/10408449209146309,
   PubMed Web of Science ®Google Scholar
• NCI, 2002. Summary of data for chemical selection - decane [online]. CAS No. 124-18-5. Available from: https://ntp.niehs.nih.gov/ntp/htdocs/chem_background/exsumpdf/apigenin_508.pdf [Accessed 24 November 2021].
   Google Scholar
• Organization for Economic Co-Operation and Development (OECD), 2002. Test no. 423: acute oral toxicity - acute toxic class method. Paris: OECD.
   Google Scholar
• Organization for Economic Co-Operation and Development (OECD), 2008. Test no. 407: repeated dose 28-day oral toxicity study in rodents. Paris: OECD.
   Google Scholar
• Ourique, F., et al., 2015. DNA damage and inhibition of Akt pathway in MCF-7 cells and Ehrlich tumor in mice treated with 1,4-naphthoquinones in combination with ascorbate. Oxidative Medicine and Cellular Longevity, 2015, 495305.
   PubMed Web of Science ®Google Scholar
• Patel, D., Zode, S.S., and Bansal, A.K., 2020. Formulation aspects of intravenous nanosuspensions. International Journal of Pharmaceutics, 586, 119555.
   PubMed Web of Science ®Google Scholar
• PROAST | RIVM [online], 2022. Available from: https://www.rivm.nl/en/proast [Accessed 1 June 2022].
   Google Scholar
• Saling, S.C., et al., 2011. Actions of juglone on energy metabolism in the rat liver. Toxicology and Applied Pharmacology, 257 (3), 319–327.
   PubMed Web of Science ®Google Scholar
• Sanders, J.M., et al., 1998. Disposition of 2-methylimidazole in rats. Journal of Toxicology and Environmental Health. Part A, 54 (2), 121–132.
   PubMed Web of Science ®Google Scholar
• Seetha, A., Devaraj, H., and Sudhandiran, G., 2020. Indomethacin and juglone inhibit inflammatory molecules to induce apoptosis in colon cancer cells. Journal of Biochemical and Molecular Toxicology, 34 (2), e22433.
   PubMed Web of Science ®Google Scholar
• Seetha, A., Devaraj, H., and Sudhandiran, G., 2021. Effects of combined treatment with Indomethacin and Juglone on AOM/DSS induced colon carcinogenesis in Balb/c mice: roles of inflammation and apoptosis. Life Sciences, 264, 118657.
   PubMed Web of Science ®Google Scholar
• Seshadri, P., Rajaram, A., and Rajaram, R., 2011. Free Radical Biology & Medicine Plumbagin and juglone induce caspase-3-dependent apoptosis involving the mitochondria through ROS generation in human peripheral blood lymphocytes. Free Radical Biology & Medicine, 51 (11), 2090–2107.
   PubMed Web of Science ®Google Scholar
• Slob, W., 2018. Joint project on Benchmark Dose modelling with RIVM. EFSA Supporting Publications, 15 (12), 1497E.
   Google Scholar
• Slob, W., 2017. A general theory of effect size, and its consequences for defining the benchmark response (BMR) for continuous endpoints. Critical Reviews in Toxicology, 47 (4), 342–351. https://doi.org/10.1080/10408444.2016.1241756
   PubMed Web of Science ®Google Scholar
• Varewyck, M., and Verbeke, T., 2019. Software for benchmark dose modelling. EFSA Supporting Publications, 14, 15.
   Google Scholar
• Wang, J., et al., 2016. Antibacterial activity of juglone against Staphylococcus aureus: from apparent to proteomic. International Journal of Molecular Sciences, 17 (6), 965.
   PubMed Web of Science ®Google Scholar
• Wang, P., et al., 2018. Juglone induces apoptosis and autophagy via modulation of mitogen-activated protein kinase pathways in human hepatocellular carcinoma cells. Food and Chemical Toxicology : An International Journal Published for the British Industrial Biological Research Association, 116 (Pt B), 40–50.
   PubMed Web of Science ®Google Scholar
• Wang, J., et al., 2016. Label-free quantitative proteomic analysis of the inhibitory activities of juglone against translation and energy metabolism in Escherichia coli. Phytochemistry Letters, 18, 55–58.
   Web of Science ®Google Scholar
• Wang, J., et al., 2016. Proteomic analysis of the antibacterial mechanism of action of juglone against Staphylococcus aureus. Natural Product Communications, 11 (6), 825–827.
   PubMed Web of Science ®Google Scholar
• Westfall, B.A., Russell, R.L., and Auyong, T.K., 1961. Depressant agent from walnut hulls. Science (New York, N.Y.), 134 (3490), 1617.
   PubMed Web of Science ®Google Scholar
• Wong, J., et al., 2008. Suspensions for intravenous (IV) injection: a review of development, preclinical and clinical aspects. Advanced Drug Delivery Reviews, 60 (8), 939–954.
   PubMed Web of Science ®Google Scholar